AC

Avinash Chandrakant Shendge

Active Director Designated Partner DIN 09209702
DIN 09209702 First appointment Jun 2021 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Avinash Chandrakant Shendge

Data last updated:

Avinash Chandrakant Shendge is a Designated Partner at Hospiserv Biomedicals Llp (since 2021). The company operates in Business Services.

DIN 09209702
Primary Designation Designated Partner
Industry Business Services
First Appointment 21 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jun 20212021Active

Board colleagues of Avinash Chandrakant Shendge

NameDINCompanyDesignation
Haridas Abaji More09209713Hospiserv Biomedicals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Hospiserv Biomedicals Llp
Premium access

Shareholding and investment profile for Avinash Chandrakant Shendge

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avinash Chandrakant Shendge

Avinash Chandrakant Shendge currently holds 1 directorship: Hospiserv Biomedicals Llp (Designated Partner, since 21 Jun 2021).

Avinash Chandrakant Shendge was first appointed on 21 Jun 2021 as Designated Partner at Hospiserv Biomedicals Llp.

The current boards of Avinash Chandrakant Shendge's companies include Haridas Abaji More (Hospiserv Biomedicals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available